Top Markets
Coin of the day
Pixium Vision S.A. Pixium Vision S.A.

Pixium Vision S.A.

ALPIX
Pozycja w akcjach #40308
Pixium Vision S.A. is a French company at the forefront of bioelectronics and... Pixium Vision S.A. is a French company at the forefront of bioelectronics and brain-machine interface technology, focusing on neuromodulation applications. The company develops the PRIMA System, a sophisticated bionic vision solution aimed at individuals experiencing profound vision loss due to retinal degeneration, specifically the dry atrophic form of Age-related Macular Degeneration (AMD). This system is engineered to combat blindness by effectively replacing the natural function of the eye's photoreceptor cells. It achieves this by electrically stimulating the nerve cells within the inner retina, which then transmit visual information to the brain via the optic nerve. Pixium Vision has established significant collaborative agreements with esteemed institutions such as Stanford University in California, the Institut de la Vision, Moorfields Eye Hospital, the Institute of Ocular Microsurgery, University Hospital, and UPMC. Founded in 2011, the company is headquartered in Paris, France.
Cena akcji
$0.40796816
Ostatnia synchronizacja: 2024-02-28
Kapitalizacja rynkowa
$181.55K
Zmiana (1 dzień)
-0.06%
Zmiana (1 rok)
0.00%
Kraj
FR
Handel Pixium Vision S.A. (ALPIX)

Kategoria

Historia stopy dywidendy dla Pixium Vision S.A. (ALPIX)
Stopa dywidendy (TTM) dla Pixium Vision S.A. (symbol akcji: ALPIX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Pixium Vision S.A. (ALPIX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji